Patents by Inventor Shingo Akimoto

Shingo Akimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123654
    Abstract: Provided is a separation and recovery apparatus for continuously separating and recovering, from a resin mixture containing a resin containing a hydrolyzable polymer and a resin containing a nonhydrolyzable polymer, a hydrolytic component a of the hydrolyzable polymer A and the nonhydrolyzable polymer B, the apparatus including: a crushing unit that crushes the resin mixture a melting/discharging unit that melts a crushed product obtained by the crushing unit to form a fluid and discharges the fluid at a high pressure; and a hydrothermal reaction treatment unit that continuously subjects the fluid discharged from the melting/discharging unit to a hydrothermal reaction treatment, wherein, in the melting/discharging unit, the hydrolyzable polymer A is hydrolyzed, and the hydrolytic component a thereof is dissolved and transferred into water permeating a sintered alloy diaphragm, thereby separating the nonhydrolyzable polymer B.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 18, 2024
    Applicant: TOPPAN INC.
    Inventors: Masaru WATANABE, Aritomo YAMAGUCHI, Osamu SATO, Yuuma IRISA, Akira TAKAMA, Kousuke NISHIMURA, Hiroki KUJIRAOKA, Hideki MIYAZAKI, Keita AKIMOTO, Takuya TAKAHATA, Daisuke KUGIMOTO, Shingo KOUDA, Satoshi HAMURA, Takahiro IMAI, Yumiko OMORI, Manabu KAWA
  • Patent number: 8148090
    Abstract: The present invention relates to a method for predicting the postoperative prognosis of a lung adenocarcinoma patient with high sensitivity and/or specificity by identifying a protein with an expression level that specifically varies in a lung adenocarcinoma patient, comprising: step (a) of determining expression levels of myosin IIA and/or vimentin in a biological sample collected from a lung adenocarcinoma patient; and step (b) of predicting or determining a prognosis based on the expression levels of myosin IIA and/or vimentin obtained as a result of determination.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: April 3, 2012
    Assignee: Medical Proteoscope Co., Ltd.
    Inventors: Yousuke Fukui, Atsushi Ogiwara, Shingo Akimoto, Takao Kawakami, Takashi Hirano, Junichi Maeda, Harubumi Kato
  • Publication number: 20100221744
    Abstract: The present invention relates to a method for predicting the postoperative prognosis of a lung adenocarcinoma patient with high sensitivity and/or specificity by identifying a protein with an expression level that specifically varies in a lung adenocarcinoma patient, comprising: step (a) of determining expression levels of myosin IIA and/or vimentin in a biological sample collected from a lung adenocarcinoma patient; and step (b) of predicting or determining a prognosis based on the expression levels of myosin IIA and/or vimentin obtained as a result of determination.
    Type: Application
    Filed: October 17, 2008
    Publication date: September 2, 2010
    Inventors: Yousuke Fukui, Atsushi Ogiwara, Shingo Akimoto, Takao Kawakami, Takashi Hirano, Junichi Maeda, Harubumi Kato